The treatment of acute lymphoblastic leukemia in Jehovah's Witnesses and patients who cannot accept blood products

Watch Tower Bible and Tract Society of Pennsylvania. Service year report of Jehovah's Witnesses worldwide. Published online 2018:1–5. https://www.jw.org/en/publications/books/2018-service-year-report/2018-country-territory/. Jehovah's Witnesses. Published online 2020. https://www.jw.org/en/jehovahs-witnesses/faq/jehovahs-witnesses-why-no-blood-transfusions/. Goldberg, 1990, Should Jehovah's Witnesses be denied intensive chemotherapy for acute leukemia?, N. Engl. J. Med, 323, 1120 Laszlo, 2004, Tailored therapy of adult acute leukaemia in Jehovah's Witnesses: unjustified reluctance to treat, Eur. J. Haematol, 72, 264, 10.1111/j.0902-4441.2003.00211.x Dezern, 2016, Red blood cell transfusion triggers in acute leukemia: a randomized pilot study, Transfusion, 56, 1750, 10.1111/trf.13658 El Chaer, 2019, Treatment of acute leukaemia in adult Jehovah's Witnesses, Br. J. Haematol Nousiainen, 1985, Jehovah's Witnesses and acute leukemia, Am. J. Hematol, 43, 158, 10.1002/ajh.2830430225 Kantarjian, 2017, Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia, N. Engl. J. Med, 376, 836, 10.1056/NEJMoa1609783 Mazza, 2003, Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience, Bone Marrow Transplant, 32, 433, 10.1038/sj.bmt.1704179 Mazza, 2000, Acute leukemia in Jehovah's Witnesses: a challenge for hematologists, Haematologica, 85, 1221 Perol, 2019, High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah's Witnesses patients: a feasible option in the age of hematopoietic growth factors, Leuk. Lymphoma, 60, 2324, 10.1080/10428194.2019.1577414 Brown, 2008, Acute myeloid leukemia in Jehovah Witnesses, Leuk. Lymphoma, 49, 817, 10.1080/10428190801911670 Shallis, 2018, Conviction in the face of affliction: a case series of Jehovah's Witnesses with myeloid malignancies, Ann. Hematol, 97, 2245, 10.1007/s00277-018-3459-6 Dalal, 2006, Treatment of acute myeloid leukemia in a Jehovah's Witness, Ann. Hematol, 85, 407, 10.1007/s00277-006-0087-3 Beck, 2020, Safety of bloodless autologous stem cell transplantation in Jehovah's Witness patients, Bone Marrow Transplant, 55, 1059, 10.1038/s41409-019-0777-9